Qube Research & Technologies (QRT)’s Novo Nordisk NVO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.9M	Sell	415,900 -31,600	-7%	-$1.36M	0.02%	913
2026 Q1	$16.4M	Sell	447,500 -233,200	-34%	-$11M	0.02%	988
2025 Q4	$34.6M	Buy	680,700 +180,000	+36%	+$9.2M	0.04%	651
2025 Q3	$27.8M	Buy	500,700 +113,500	+29%	+$6.64M	0.03%	730
2025 Q2	$26.7M	Buy	387,200 +131,600	+51%	+$8.95M	0.03%	729
2025 Q1	$17.7M	Buy	255,600 +97,700	+62%	+$8.07M	0.02%	802
2024 Q4	$13.6M	Sell	157,900 -12,000	-7%	-$1.3M	0.02%	915
2024 Q3	$20.2M	Buy	169,900 +144,600	+572%	+$19.3M	0.03%	660
2024 Q2	$3.61M	Buy	+25,300	New	+$3.35M	0.01%	1408
2024 Q1	–	Sell	-23,500	Closed	-$2.43M	–	4746
2023 Q4	$2.43M	Buy	+23,500	New	+$2.32M	﹤0.01%	1423

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Qube Research & Technologies (QRT)'s NVO Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Novo Nordisk (NVO) in Q2 2026: 520,267 shares worth $24.9M. The stake represents 0.02% of the portfolio and ranks #811 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in NVO as recently as Q4 2025.

Qube Research & Technologies (QRT) first reported a position in NVO in Q1 2018 and has held it in 21 quarters since. The position peaked at $104M in Q2 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Qube Research & Technologies (QRT) held 520,267 shares of Novo Nordisk worth $24.9M as of Q2 2026.
Novo Nordisk was a new Qube Research & Technologies (QRT) position in Q2 2026.
Novo Nordisk made up 0.02% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #811 holding.
Qube Research & Technologies (QRT) first reported a position in Novo Nordisk in Q1 2018 and has held it in 21 quarters since.
Qube Research & Technologies (QRT)'s Novo Nordisk position peaked at $104M in Q2 2024.
1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.